ACT EU aims to address the paucity of multi-national clinical trials in the European innovative environment
- The E.U. has an extensive life science research and healthcare sector to support innovation. The E.U. has a rich pharmaceutical industry that spent EUR 39 billion on research and development alone in 2020, according to an EFPIA report on its members’ expenditures.
Fill out the form to read the full article.